Olfactory Disorder: Clinical Trials

1 trial for Olfactory Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1
Phase 31Recruiting 1

Follow Olfactory Disorder: new trials by email Literature Review of Olfactory Disorder trials Research Report on Olfactory Disorder

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
Trigeminal Nerve Stimulation (TNS), Active Smell Training (ST), Placebo Smell Training (PBO) - Smell Dysfunction, Olfactory Disorder
Phase 2 / Phase 3RecruitingMedical University of South Carolina1452023-10-022026-04-02

Narrower conditions

Anosmia (1)  ·  COVID-19 (1)  ·  Olfaction Disorders (1)  ·  Post-Acute COVID-19 Syndrome (1)

Broader conditions

Chronic Disease (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Disease Attributes (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Nidovirales Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  Post-Infectious Disorders (1)  ·  RNA Virus Infections (1)

Interventions

Olfactory Training (1)  ·  Transcutaneous Electric Nerve Stimulation (1)

Sponsors

Medical University of South Carolina (1)

Countries

United States (1)

NIH funding

R01DC021179 (1)